- Home
- FTS vs LH Comparison
FTS vs LH Comparison
Compare FTS & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTS
- LH
- Stock Information
- Founded
- FTS 1885
- LH 1971
- Country
- FTS Canada
- LH United States
- Employees
- FTS N/A
- LH N/A
- Industry
- FTS Electric Utilities: Central
- LH Medical Specialities
- Sector
- FTS Utilities
- LH Health Care
- Exchange
- FTS Nasdaq
- LH Nasdaq
- Market Cap
- FTS 24.4B
- LH 20.2B
- IPO Year
- FTS N/A
- LH N/A
- Fundamental
- Price
- FTS $47.04
- LH $261.88
- Analyst Decision
- FTS Hold
- LH Strong Buy
- Analyst Count
- FTS 1
- LH 15
- Target Price
- FTS $72.00
- LH $271.57
- AVG Volume (30 Days)
- FTS 461.0K
- LH 618.0K
- Earning Date
- FTS 07-30-2025
- LH 07-31-2025
- Dividend Yield
- FTS 3.72%
- LH 1.10%
- EPS Growth
- FTS 5.83
- LH 73.29
- EPS
- FTS 2.30
- LH 8.67
- Revenue
- FTS $8,159,460,114.00
- LH $13,177,400,000.00
- Revenue This Year
- FTS $10.96
- LH $10.03
- Revenue Next Year
- FTS $4.24
- LH $4.82
- P/E Ratio
- FTS $20.54
- LH $30.16
- Revenue Growth
- FTS 3.64
- LH 7.13
- 52 Week Low
- FTS $38.15
- LH $198.96
- 52 Week High
- FTS $50.06
- LH $264.03
- Technical
- Relative Strength Index (RSI)
- FTS 42.07
- LH 64.16
- Support Level
- FTS $47.14
- LH $258.39
- Resistance Level
- FTS $48.62
- LH $263.51
- Average True Range (ATR)
- FTS 0.57
- LH 4.34
- MACD
- FTS -0.11
- LH 0.31
- Stochastic Oscillator
- FTS 13.79
- LH 89.42
About FTS Fortis Inc.
Fortis owns and operates eight utility transmission and distribution subsidiaries in Canada and the United States, serving more than 3.4 million electricity and gas customers. The company has smaller stakes in electricity generation and several Caribbean utilities. Subsidiary ITC operates electric transmission in seven US states, with more than 16,000 miles of high-voltage transmission lines in operation.
About LH Laboratory Corporation of America Holdings
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.